Product Information

RAMELTEON 8 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6771 per EA under NDC 59651050501. Its NADAC has been published 141 times since Mar 13, 2024.

FDA first approved this application on Jul 10, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RAMELTEON 8 MG TABLET

RAMELTEON
$0.6771per EA

Strength

8 mg/1

NDC

59651050501

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

RAMELTEON

Approval Type

Generic (ANDA)

FDA Application

ANDA215972

FDA Approved

7/10/2023

TE Code

AB

On Market Since

7/10/2023

Pharmacological Classes

Melatonin Receptor Agonist
Melatonin Receptor Agonists

Price Statistics

The NADAC for RAMELTEON 8 MG TABLET has been published 141 times since Mar 13, 2024, and over the history we have for it it has declined 25.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6771 per EA
All-time high$0.9260 (Apr 10, 2024)
All-time low$0.5491 (Nov 20, 2024)
52-week high$0.7622
52-week low$0.6575
Median price$0.7172
Average price$0.7315
Largest weekly change+50.1% (Aug 21, 2024)
Weeks tracked141
Tracking sinceMar 13, 2024

Price History

1W

+1.7%

1M

+2.6%

3M

+3.0%

6M

-5.3%

1Y

-6.9%

3Y

N/A

5Y

N/A

All

-25.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RAMELTEON 8 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RAMELTEON 8 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.6771 per EA (NDC 59651050501), effective Nov 18, 2026.

How has the price of RAMELTEON 8 MG TABLET changed over time?

Over the history we have for it, the NADAC for RAMELTEON 8 MG TABLET has declined 25.9%. It has been tracked across 141 weekly CMS publications since Mar 13, 2024.

What are the highest and lowest recorded NADAC prices for RAMELTEON 8 MG TABLET?

Since Mar 13, 2024, the NADAC for RAMELTEON 8 MG TABLET has ranged from a low of $0.5491 (Nov 20, 2024) to a high of $0.9260 (Apr 10, 2024), with a median of $0.7172 per EA.

Are there cheaper alternatives to RAMELTEON 8 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as RAMELTEON 8 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures RAMELTEON 8 MG TABLET?

RAMELTEON 8 MG TABLET (NDC 59651050501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.